Literature DB >> 15454124

Palindromic rheumatism and other relapsing arthritis.

Raimon Sanmarti1, Juan D Cañete, Georgina Salvador.   

Abstract

Patients with recurrent or relapsing arthritis are frequently seen in rheumatological practice. Besides crystal arthritis, the most frequent cause of recurrent arthritis, there are several diseases that may present clinically as intermittent mono- or polyarthritis. Palindromic rheumatism is the paradigm of this type of condition, but other diseases such as systemic autoinflammatory disorders (periodic fever syndromes), Whipple's disease, arthritis associated with hyperlipidemia, intermittent hydrarthrosis and other diseases should be taken into account in the differential diagnosis of patients with recurrent arthritis. In this chapter, we discuss recent developments in these diseases with special emphasis on palindromic rheumatism, a common condition whose close relationship with rheumatoid arthritis remains intriguing.

Entities:  

Mesh:

Year:  2004        PMID: 15454124     DOI: 10.1016/j.berh.2004.05.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  11 in total

1.  The prevalence of Tropheryma whippelii DNA in saliva from healthy controls and patients with spondyloarthropathy.

Authors:  Jin-Wuk Hur; Young-In Na; Tae-Hwan Kim; Shin-Young Yim; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

Review 2.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

3.  Magnetic resonance imaging of palindromic rheumatism.

Authors:  Satoko Ueda; Taro Horino; Kaoru Arii; Tatsuhito Morita; Toshihiro Takao; Kozo Hashimoto
Journal:  Rheumatol Int       Date:  2008-07-29       Impact factor: 2.631

Review 4.  Palindromic rheumatism: a descriptive report of seven cases from North Dakota and a short review of literature.

Authors:  Prashant Kaushik
Journal:  Clin Rheumatol       Date:  2009-09-22       Impact factor: 2.980

5.  In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up.

Authors:  Yasser Emad; Ashraf Anbar; Ihab Abo-Elyoun; Nashwa El-Shaarawy; Hadeel Al-Hanafi; Hatem Darwish; Mona Gamil; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2014-03-13       Impact factor: 2.980

Review 6.  The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis.

Authors:  Panagiota Papanagnou; Theodora Stivarou; Maria Tsironi
Journal:  Biomolecules       Date:  2016-11-11

7.  Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.

Authors:  Ching-Heng Lin; Der-Yuan Chen; Wen-Cheng Chao; Tsai-Ling Liao; Yi-Ming Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

8.  Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.

Authors:  Raul Castellanos-Moreira; Sebastian C Rodriguez-Garcia; Sonia Cabrera-Villalba; María José Gomara; Georgina Salvador; Virginia Ruiz-Esquide; Julio Ramirez; Jose Inciarte-Mundo; Rosa Morla; Cristina Garcia-Moreno; Andrea Cuervo; Jose A Gómez-Puerta; Juan D Cañete; Isabel Haro; Raimon Sanmarti
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-10       Impact factor: 5.346

9.  Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?

Authors:  Raimon Sanmartí; Beatriz Frade-Sosa; Rosa Morlà; Raul Castellanos-Moreira; Sonia Cabrera-Villalba; Julio Ramirez; Georgina Salvador; Isabel Haro; Juan D Cañete
Journal:  Front Med (Lausanne)       Date:  2021-03-25

10.  Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.

Authors:  Hsin-Hua Chen; Wen-Cheng Chao; Tsai-Ling Liao; Ching-Heng Lin; Der-Yuan Chen
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.